Does Tirzepatide Affect Your Resting Heart Rate?

Step 1: Understand why the increase happens at all

GLP-1 receptor agonists (and tirzepatide specifically, which also activates GIP receptors) have a mild stimulatory effect on the sympathetic nervous system. That autonomic nudge is enough to push resting heart rate up by a few beats per minute in many people. It is not a sign that the heart is under strain. The mechanism is pharmacological: the medicine influences the autonomic tone that sets your baseline pulse, much the same way caffeine can nudge it temporarily, though the effect here is steadier and more sustained.

SURMOUNT-1, the pivotal phase-3 trial published in the New England Journal of Medicine, documented this across thousands of adults. The increases observed were modest across all doses tested, and they did not translate into an increase in serious cardiac events in that trial population. That is reassuring context, though it is not a blank cheque: people with pre-existing arrhythmias or poorly controlled heart conditions require careful prescriber assessment before starting tirzepatide.

Knowing this helps you interpret your fitness tracker sensibly. A wearable showing 64 bpm instead of your usual 60 bpm is within expected territory. What matters more is the trend, your symptoms, and how that number sits alongside everything else your clinician knows about you. Our page on tirzepatide and heart rate goes into the underlying physiology in more detail if you want to read further.

Step 2: Track what your baseline actually is

Many people discover their resting heart rate almost by accident — a new smartwatch, a GP appointment, or the moment they start paying closer attention to their health. If you did not have a reliable baseline before starting tirzepatide, it is harder to know whether a reading of, say, 72 bpm represents a rise or is simply your normal.

The useful approach is to measure at the same time each day, ideally first thing in the morning before you get out of bed, for at least a week before your consultation and again after starting treatment. Healthy resting heart rate for adults generally sits between 60 and 100 bpm, with many active adults sitting in the 55–75 range. A small upward shift within that band is not clinically significant for most people. The concern threshold that most prescribers watch for is a consistent reading above 100 bpm (resting tachycardia) or any new palpitations that feel rapid, irregular or accompanied by chest tightness.

If you are monitoring closely and seeing numbers that worry you, the right step is a conversation with your prescriber, not reducing your dose independently. Dose timing and titration decisions should always sit with the clinical team reviewing your treatment, there is more on the broader cardiac picture at our tirzepatide and heart health page.

Step 3: Weigh the short-term rise against the longer-term cardiac picture

Here is the part that often gets lost in short online summaries. Sustained excess weight is itself a significant driver of elevated resting heart rate. The heart works harder when it is perfusing a larger body mass, and years of that workload leave a mark. As tirzepatide supports meaningful weight loss over months (SURMOUNT-1 reported average reductions of around 20% of body weight at the highest dose) many people see their resting heart rate fall over the medium term, even if it ticked up slightly at the start.

The NICE appraisal of tirzepatide, TA1026, notes the weight-management benefits for adults with obesity and weight-related conditions. For people with cardiovascular risk factors, the metabolic improvements that come with significant weight loss (lower blood pressure, improved lipid profiles, better glucose control) are likely to matter more to long-term heart health than a 2 or 3 bpm uptick in resting pulse during the early months.

That said, tirzepatide is not currently licensed as a cardiovascular-risk medicine in the UK; its licence is weight management, assessed for you individually by a prescriber. Anyone with a diagnosed heart condition should discuss their specific situation before starting. Our tirzepatide and heart disease page covers those specific scenarios. If you are also wondering about lifestyle factors that interact with treatment, our page on whether you can drink on Mounjaro is worth a read, as alcohol can independently affect heart rate and hydration. More general information on what Mounjaro does to the cardiovascular system is on our Mounjaro heart rate page.

Step 4: Know when a raised heart rate warrants urgent attention

Most of the time, a modest resting heart rate increase on tirzepatide is a monitoring point, not an emergency. But some patterns need prompt clinical input. If you want a fuller picture of what to watch for, our guide to Mounjaro and a fast heart rate explains the specific symptoms that should prompt you to contact a clinician. Contact your prescriber or seek medical attention if your resting heart rate is consistently above 100 bpm at rest, if you notice palpitations that feel rapid or irregular, or if any heart-rate change comes alongside chest pain, shortness of breath or fainting.

Dehydration can also push heart rate up, and nausea or vomiting early in treatment can make staying well-hydrated harder. If your elevated reading coincides with a bout of gastrointestinal side effects, addressing the hydration gap often helps the numbers settle. That said, do not try to self-diagnose the cause.

Suspected side effects, including any cardiovascular symptoms you think may be linked to your treatment, can be reported through the MHRA Yellow Card scheme, open to patients as well as healthcare professionals. If you have questions about whether tirzepatide suits your particular health picture, our prescribers can walk through it with you. You can also find answers to common treatment questions on our FAQs page. When you are ready to take the next step, check your eligibility with a free consultation and a real prescriber will review your details the same day.